1. Home
  2. KXIN vs CVKD Comparison

KXIN vs CVKD Comparison

Compare KXIN & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KXIN
  • CVKD
  • Stock Information
  • Founded
  • KXIN 2015
  • CVKD 2022
  • Country
  • KXIN China
  • CVKD United States
  • Employees
  • KXIN N/A
  • CVKD N/A
  • Industry
  • KXIN Retail-Auto Dealers and Gas Stations
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • KXIN Consumer Discretionary
  • CVKD Health Care
  • Exchange
  • KXIN Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • KXIN 13.0M
  • CVKD 29.5M
  • IPO Year
  • KXIN N/A
  • CVKD 2023
  • Fundamental
  • Price
  • KXIN $0.90
  • CVKD $11.47
  • Analyst Decision
  • KXIN
  • CVKD Strong Buy
  • Analyst Count
  • KXIN 0
  • CVKD 1
  • Target Price
  • KXIN N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • KXIN 80.5K
  • CVKD 33.0K
  • Earning Date
  • KXIN 01-01-0001
  • CVKD 08-06-2025
  • Dividend Yield
  • KXIN N/A
  • CVKD N/A
  • EPS Growth
  • KXIN N/A
  • CVKD N/A
  • EPS
  • KXIN N/A
  • CVKD N/A
  • Revenue
  • KXIN N/A
  • CVKD N/A
  • Revenue This Year
  • KXIN N/A
  • CVKD N/A
  • Revenue Next Year
  • KXIN N/A
  • CVKD N/A
  • P/E Ratio
  • KXIN N/A
  • CVKD N/A
  • Revenue Growth
  • KXIN N/A
  • CVKD N/A
  • 52 Week Low
  • KXIN $0.64
  • CVKD $5.70
  • 52 Week High
  • KXIN $29.54
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • KXIN 53.15
  • CVKD 40.38
  • Support Level
  • KXIN $0.90
  • CVKD $10.02
  • Resistance Level
  • KXIN $1.10
  • CVKD $13.71
  • Average True Range (ATR)
  • KXIN 0.06
  • CVKD 1.08
  • MACD
  • KXIN 0.01
  • CVKD -0.13
  • Stochastic Oscillator
  • KXIN 48.98
  • CVKD 29.72

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: